121 related articles for article (PubMed ID: 11959001)
1. Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin.
Kasai S; Nagasawa H; Shimamura M; Uto Y; Hori H
Bioorg Med Chem Lett; 2002 Mar; 12(6):951-4. PubMed ID: 11959001
[TBL] [Abstract][Full Text] [Related]
2. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
3. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
[TBL] [Abstract][Full Text] [Related]
4. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
5. Collagen XVIII/endostatin structure and functional role in angiogenesis.
Zatterstrom UK; Felbor U; Fukai N; Olsen BR
Cell Struct Funct; 2000 Apr; 25(2):97-101. PubMed ID: 10885579
[TBL] [Abstract][Full Text] [Related]
6. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo.
Cattaneo MG; Pola S; Francescato P; Chillemi F; Vicentini LM
Exp Cell Res; 2003 Feb; 283(2):230-6. PubMed ID: 12581742
[TBL] [Abstract][Full Text] [Related]
7. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution.
Hohenester E; Sasaki T; Olsen BR; Timpl R
EMBO J; 1998 Mar; 17(6):1656-64. PubMed ID: 9501087
[TBL] [Abstract][Full Text] [Related]
9. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of collagen-derived endostatin inhibitors of angiogenesis.
Sasaki T; Hohenester E; Timpl R
IUBMB Life; 2002 Feb; 53(2):77-84. PubMed ID: 12049199
[TBL] [Abstract][Full Text] [Related]
11. Effect of human recombinant Endostatin protein on human angiogenesis.
Jung SP; Siegrist B; Hornick CA; Wang YZ; Wade MR; Anthony CT; Woltering EA
Angiogenesis; 2002; 5(1-2):111-8. PubMed ID: 12549868
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
[TBL] [Abstract][Full Text] [Related]
13. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives.
Nagasawa H; Yamashita M; Mikamo N; Shimamura M; Oka S; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):33-40. PubMed ID: 12062188
[TBL] [Abstract][Full Text] [Related]
15. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.
Sasaki T; Fukai N; Mann K; Göhring W; Olsen BR; Timpl R
EMBO J; 1998 Aug; 17(15):4249-56. PubMed ID: 9687493
[TBL] [Abstract][Full Text] [Related]
16. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
17. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
18. Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.
Kruger EA; Duray PH; Tsokos MG; Venzon DJ; Libutti SK; Dixon SC; Rudek MA; Pluda J; Allegra C; Figg WD
Biochem Biophys Res Commun; 2000 Feb; 268(1):183-91. PubMed ID: 10652234
[TBL] [Abstract][Full Text] [Related]
19. Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide.
Yin R; Zheng H; Xi T; Xu HM
Bioconjug Chem; 2010 Jul; 21(7):1142-7. PubMed ID: 20515045
[TBL] [Abstract][Full Text] [Related]
20. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
